Author: Remzi Avci (Turkey)
Co-authors: Aysegul Mavi Yildiz, Sami Yilmaz
Purpose
Retinal capillary hemangioblastoma (RCH) are rare benign tumours, usually associated with von Hippel-Lindau (VHL) disease. Various treatment options including; argon laser photocoagulation, cryotherapy, plaque radiotherapy and vitreoretinal surgery have been suggested for the management of RCH. However, no consensus exists regarding the ideal treatment method. The aim of our study was to assess results of vitreoretinal surgery with excision of retinal capillary hemangioblastomas in von Hippel-Lindau (VHL) disease.
Setting/Venue
Retrospective, interventional, case series
Methods
An electronic database search was performed. We identified 23 patients who underwent 23 G vitrectomy and tumor resection for retinal detachment (RD) associated with RCHs between January 2001 and January 2020. Primary outcome measures were anatomic success rate and final visual acuity (VA).
Results
The mean age was 32.04±12.08 (range 12-58) years and mean follow up was 20.7±12.68 (range 4-44) months. Of the patients, 30.4% (n=7/23) got unilateral onset and 69.5% (n=16/23), suffered bilaterally. Ten of the patients had multiple RCHs whereas 13 had solitary tumor. The size of the tumor ranged from 2 disc diameters (DD) to 5 DD. The location of the tumor was classed into 3 groups; preretinal (n=8/23), intraretinal (n=17/23) and subretinal (n=7/23). All of the patients (n=23/23) had exudative retinal detachment, %78.2 (n=18/23) also had severe proliferative vitreoretinopathy and 4.3% (n=1/23) had a full thickness macular hole. Of the 23 patients/detachments; 47.8% (n=11/23) were total and 52.1% (n=12/23) were subtotal. 43.7% (n=10/23) of the patients had undergone non-surgical treatments (argon laser photocoagulation: n=6/23, photodynamic treatment: n=3/23, intravitreal anti-VEGF injection: n=1/23 and plaque radiothreaphy: n=1/23) preoperatively. All patients underwent 23 G pars plana vitrectomy, tumor resection and endolaser photocoagulation. In addition, relaxing retinectomy (n=8/23) and proliferative membrane removal (n=18/23) was performed if needed. Silicone oil was used in 9 cases, %14 C3F8 gas was used in 13 cases and air tamponade was used in one case. The mean preoperative and postoperative VA were; LogMAR 1.78±1.14 (range LP-0.1) and LogMAR 1.04±1.11 (range LP-0.0) respectively (p=0.002). Visual acuity improved in 18 patients (mean 0.58±0.84 LogMAR; range: 1.0-2.6), remained stable at hand motion perception in 3 patient and decreased in 2 patients due to recurrent tractional RD. No intraoperative complications occurred. Postoperative complications included macular hole formation (n = 1/23) and recurrent tractional RD (n=2/23). There was also 1 case of new tumor, which was effectively treated with repeat vitrectomy. At the last follow-up visit, the retina was attached in all patients.
Conlusions
Vitrectomy with RCH excision is a safe and effective method for the treatment of large tumors complicated with exudative and/or tractional retinal detachment. Surgical resection of large retinal hemangioblastomas and complete removal of proliferative membranes are the most important points of surgery. However, life long follow-up is recommended to diagnose and treat recurrences.
Financial Disclosure
We have no financial relationships
Comments
-